Clinical Trials Archives

Publication

Establishing Immune Correlates of Protection Against Respiratory Syncytial Virus Infection to Accelerate Vaccine Development: A Model-Based Meta-Analysis

Bridge across studies with Model-based Meta Analysis, incorporating broader data & synthetic patients to enhance…

CertaraOctober 31, 2025

Conference

Dutch Medicines Days

CertaraOctober 7, 2025

Case Study

Certara & Dizal Partner to Fast-Track FDA Approval of Sunvozertinib for Lung Cancer

Certara’s support enabled fast-track FDA oncology approval 2025 for Sunvozertinib, a breakthrough NSCLC therapy targeting…

CertaraOctober 2, 2025

Announcement

Certara Launches DIDB® Concomitant Meds Navigator, Extending Leadership in Drug Interaction Science

Meet DIDB Concomitant Meds Navigator—an evidence-based tool to identify contraindicated or monitored co-medications and manage…

CertaraSeptember 22, 2025

Blog

FAQs on Developing EMA Policy 0070 Submissions

This blog answers audience questions posed during our RAPS webinar, How to Plan for a…

CertaraSeptember 15, 2025

Guide

The Top 10 Things You Need to Know About ADNCA Datasets

Learn how ADNCA datasets can modernize non-compartmental analysis: enhanced compliance, automations, and faster PK data…

CertaraSeptember 11, 2025

Conference

Redefining Every Stage of Investment (RESI) Seed to Exit

CertaraSeptember 5, 2025

Case Study

Large Biotech Streamlines Investigator’s Brochures with Certara’s Project Management Expertise

Learn how Certara's project management team helped a large biotech streamline the development and updates…

CertaraSeptember 5, 2025

Conference

The Pharmacometrics Africa Conference 2025 (PMXAC-2025)

CertaraSeptember 4, 2025

On-Demand Webinar

The Many Challenges of Patient Narrative Writing | RAPS Sponsored Webinar

Watch Certara’s RAPS-sponsored on-demand webinar to learn how automation and expert strategies simplify patient narrative…

CertaraAugust 18, 2025

Clinical Trials

Establishing Immune Correlates of Protection Against Respiratory Syncytial Virus Infection to Accelerate Vaccine Development: A Model-Based Meta-Analysis

Dutch Medicines Days

Certara & Dizal Partner to Fast-Track FDA Approval of Sunvozertinib for Lung Cancer

Certara Launches DIDB® Concomitant Meds Navigator, Extending Leadership in Drug Interaction Science

FAQs on Developing EMA Policy 0070 Submissions

The Top 10 Things You Need to Know About ADNCA Datasets

Redefining Every Stage of Investment (RESI) Seed to Exit

Large Biotech Streamlines Investigator’s Brochures with Certara’s Project Management Expertise

The Pharmacometrics Africa Conference 2025 (PMXAC-2025)

The Many Challenges of Patient Narrative Writing | RAPS Sponsored Webinar

Newsletter sign up

Quick links

Solutions

Contact